These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9855623)

  • 1. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
    Schmidt K; Schrammel A; Koesling D; Mayer B
    Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
    Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
    J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets.
    Becker EM; Schmidt P; Schramm M; Schröder H; Walter U; Hoenicka M; Gerzer R; Stasch JP
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):390-7. PubMed ID: 10710123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
    Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
    Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
    Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
    Friebe A; Koesling D
    Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
    Mullershausen F; Russwurm M; Friebe A; Koesling D
    Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
    Ott SR; Delago A; Elphick MR
    Eur J Neurosci; 2004 Sep; 20(5):1231-44. PubMed ID: 15341595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
    Wu CC; Ko FN; Teng CM
    Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
    Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
    Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.